Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Fogarty

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Scientific Reports|November 30, 2016
Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosisMatthew J Fogarty, Paul M Klenowski, John D Lee, et al.
Frontiers in Physiology|October 8, 2021
Modulation of Vagal Sensory Neurons <i>via</i> High Mobility Group Box-1 and Receptor for Advanced Glycation End Products: Implications for Respiratory Viral InfectionsStuart B Mazzone, Seung-Kwon Yang, Jennifer A Keller, et al.
EMBO Molecular Medicine|March 17, 2022
CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotypeAntoine de Zélicourt, Abdallah Fayssoil, Mbarka Dakouane-Giudicelli, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Scientific Reports|November 30, 2016
Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosisMatthew J Fogarty, Paul M Klenowski, John D Lee, et al.
Frontiers in Physiology|October 8, 2021
Modulation of Vagal Sensory Neurons <i>via</i> High Mobility Group Box-1 and Receptor for Advanced Glycation End Products: Implications for Respiratory Viral InfectionsStuart B Mazzone, Seung-Kwon Yang, Jennifer A Keller, et al.
EMBO Molecular Medicine|March 17, 2022
CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotypeAntoine de Zélicourt, Abdallah Fayssoil, Mbarka Dakouane-Giudicelli, et al.
Pageof 9